David A. Wacker
Impact in
-
- PARP inhibition in cancer therapy
-
- Genomics and Chromatin Dynamics
- DNA Repair Mechanisms
- DNA and Nucleic Acid Chemistry
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- RNA and protein synthesis mechanisms
Papers in
-
- Genomics and Chromatin Dynamics 4
- DNA Repair Mechanisms 2
- RNA Research and Splicing 2
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- W. Lee Kraus (3 shared papers)Tong Zhang (2 shared papers)Brent D. Brower‐Toland (1 shared paper)Michelle D. Wang (1 shared paper)Robert M. Fulbright (1 shared paper)John T. Lis (1 shared paper)Donald D. Ruhl (1 shared paper)Ehsan H. Balagamwala (1 shared paper)
- Journals
- Molecular and Cellular Biology (1 paper)Journal of Cellular Biochemistry (1 paper)Acute and Critical Care (1 paper)Scientific Reports (1 paper)Journal of Molecular Biology (1 paper)
- Partner nations
- United StatesSweden
In The Last Decade
David A. Wacker
10 papers receiving 387 citations
Peers
Comparison fields: 5 of 73
- Oncology 121
- Molecular Biology 263
- Critical Care and Intensive Care Medicine 15
- Physiology 13
- Infectious Diseases 45
Countries citing papers authored by David A. Wacker
This map shows the geographic impact of David A. Wacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Wacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Wacker more than expected).
Fields of papers citing papers by David A. Wacker
This network shows the impact of papers produced by David A. Wacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Wacker. The network helps show where David A. Wacker may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Wacker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 156 | |
| 2 | 2007 | 114 | |
| 3 | 2021 | 49 | |
| 4 | 2007 | 31 | |
| 5 | 2014 | 17 | |
| 6 | 2022 | 8 | |
| 7 | 2015 | 7 | |
| 8 | 2009 | 6 | |
| 9 | 2023 | 1 | |
| 10 | Managing patients with oncologic complications in the emergency department [digest]. | 2018 | 1 |
| 11 | 2023 | 0 | |
| 12 | 2021 | 0 |
About David A. Wacker
David A. Wacker is a scholar working on Molecular Biology, Infectious Diseases, Oncology, Emergency Medicine and Neurology, having authored 12 papers that have together received 390 indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (4 papers), COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), DNA Repair Mechanisms (2 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers), RNA Research and Splicing (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Oncology (121 citations), Molecular Biology (263 citations), Critical Care and Intensive Care Medicine (15 citations), Physiology (13 citations) and Infectious Diseases (45 citations). David A. Wacker has collaborated with scholars based in United States and Sweden. Frequent co-authors include W. Lee Kraus, Tong Zhang, Brent D. Brower‐Toland, Michelle D. Wang, Robert M. Fulbright, John T. Lis, Donald D. Ruhl, Ehsan H. Balagamwala, Kristine M. Hope and Michael E. Winters. Their work appears in journals such as Molecular and Cellular Biology, Journal of Cellular Biochemistry, Acute and Critical Care, Scientific Reports and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.